Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?

Alessio FinocchiaroMarco PaciottiRoberto ContieriVittorio FasuloAlberto SaitaGiovanni LughezzaniNicolo Maria BuffiMassimo LazzeriRodolfo HurlePaolo Casale

Published in: BJU international (2024)

Keyphrases

low grade
muscle invasive bladder cancer
high grade
human health
combination therapy
climate change